Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19

被引：0
|
作者：
Lewis-Wolfson, Temeka Dawn [1 ]
Joyner, Kayla Rena [2 ,3 ]
机构：
[1] Winchester Med Ctr, Pharm Dept, Winchester, VA 22601 USA
[2] Shenandoah Univ, Bernard J Dunn Sch Pharm, Dept Pharm Practice, Winchester, VA USA
[3] Winchester Med Ctr, Trauma & Acute Care Surg, Winchester, VA USA
来源：
ANNALS OF PHARMACOTHERAPY | 2023年 / 57卷 / 09期
关键词：
D O I：
10.1177/10600280221144936
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1118 / 1119
页数：2
相关论文
共 50 条
  • [41] Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply
    Aomar-Millan, Ismael Francisco
    Salvatierra, Juan
    Hernandez-Quero, Jose
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (04) : 1105 - 1106
  • [42] Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
    Roddy, John
    Wells, Daniel
    Schenck, Katharine
    Santosh, Shrihari
    Santosh, Sadashiv
    [J]. CRITICAL CARE EXPLORATIONS, 2022, 4 (05)
  • [43] Repurposed Tocilizumab in Patients with Severe COVID-19
    Tian, Jianbo
    Zhang, Ming
    Jin, Meng
    Zhang, Fengqin
    Chu, Qian
    Wang, Xiaoyang
    Chen, Can
    Yue, Huihui
    Zhang, Li
    Du, Ronghui
    Zhao, Dong
    Zeng, Zhaofu
    Zhao, Yang
    Liu, Kui
    Wang, Mengmei
    Hu, Ke
    Miao, Xiaoping
    Zhang, Huilan
    [J]. JOURNAL OF IMMUNOLOGY, 2021, 206 (03): : 599 - 606
  • [44] Clinical experience with tocilizumab in the treatment of pregnant woman with severe COVID-19
    Riabokon, O., V
    Kuliesh, I. O.
    Furyk, O. O.
    Matvieieva, T. B.
    Kalashnyk, K., V
    [J]. PATHOLOGIA, 2022, 19 (01): : 79 - 83
  • [45] Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients
    Guz, Dmitri
    Gafter-Gvili, Anat
    Lev, Nirit
    Levin, Gal Sahaf
    Lev, Shaul
    [J]. ACTA HAEMATOLOGICA, 2022, 145 (04) : 440 - 446
  • [46] Tocilizumab in severe COVID-19: A promise fulfilled
    Levi, Marcel
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 95 : 38 - 39
  • [47] Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients
    Zeng, Jia
    Xie, Ming-Hui
    Yang, Jing
    Chao, Sheng-Wu
    Xu, Er-Li
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3763 - 3773
  • [48] Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study
    Kewan, Tariq
    Covut, Fahrettin
    Al-Jaghbeer, Mohammed J.
    Rose, Lori
    Gopalakrishna, K., V
    Akbik, Bassel
    [J]. ECLINICALMEDICINE, 2020, 24
  • [49] Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
    Zielecki, Piotr
    Kaniewska, Magdalena
    Furmanek, Mariusz
    Bulski, Tomasz
    Rydzewska, Grazyna
    [J]. GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2020, 15 (03): : 267 - 272
  • [50] Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report
    Xu, C. -Y.
    Lu, S. -D.
    Ye, X.
    Cao, M. -Y.
    Xu, G. -D.
    Yu, Q.
    Qian, J. -X.
    Zeng, G.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (08) : 569 - 572
12345